Latest News about DEA
Recent news which mentions DEA
DEA Sanctions Religious Use Of Ayahuasca But Refuses Psilocybin For Cancer Patients' Pain Relief
April 24, 2024
From Benzinga
DEA Public Comment Period And A Cannabis-Related Crypto Bill? You Heard It First At Benzinga Conference
April 19, 2024
From Benzinga
Analyst Reacts To FDA Commish Comments: Medical And Recreational Cannabis Could Have Separate Regulations
April 12, 2024
From Benzinga
FDA Commissioner To House Committee: 'There's No Reason For DEA To Delay' Cannabis Rescheduling
April 12, 2024
From Benzinga
Why Real Estate Stocks Were Hurting Today
April 10, 2024
From Motley Fool
'This Is Insanity, Someone's Got To Act,' Marijuana Researcher Files Fed Lawsuit Against DEA Over 'Unconstitutional Process'
April 10, 2024
From Benzinga
These Top REITs Have Yields Up to 9.1%
April 09, 2024
From Benzinga
EXCLUSIVE: DEA-Licensed Cannabis Co. Maridose To Launch Series A Funding Round At Upcoming Benzinga Conference
April 05, 2024
From Benzinga
DEA Revisits Proposed Ban On Two Psychedelic Compounds: Researchers Disagree, Insist On Hearings
April 02, 2024
From Benzinga
From Benzinga
DEA Comes Out Of The Shadows To Ensure Cannabis Rescheduling Process Is Not Being Done Under 'Shroud Of Secrecy'
March 28, 2024
From Benzinga
GOP Mitt Romney Pens Letter To DEA Bashing Cannabis Rescheduling, Dems' Letter To DOJ Bashes Broken Promises
March 27, 2024
From Benzinga
Rep. Blumenauer Grills Fed Health Agency For Clarity On Cannabis Rescheduling As Debate Heats Up
March 21, 2024
From Benzinga
From Benzinga
VP Kamala Harris Urges DEA To Reschedule Cannabis 'As Quickly As Possible,' Calls Prohibition 'Absurd' & 'Unfair'
March 15, 2024
From Benzinga
From Benzinga
GOP Sen. John Cornyn Takes Health Secretary To Task Over Cannabis Rescheduling: Xavier Becerra Holds His Own
March 14, 2024
From Benzinga
DEA Vs. White House: Agency Pushes Back On Medical Benefits Of Cannabis, Weed Stocks Wobble
March 11, 2024
From Benzinga
These High-Quality REITs Have Yields Over 7%
March 05, 2024
From Benzinga
Monday Is Your Last Chance To Buy Easterly Government Props Before The Dividend Payout
February 29, 2024
Tickers
DEA
From Benzinga
Congresswoman To DEA: 'Reject Any Argument' That Marijuana Rescheduling Violates US Treaty Obligations
February 27, 2024
From Benzinga
Earnings Scheduled For February 27, 2024
February 27, 2024
From Benzinga
Congresswoman Barbara Lee Says Marijuana Rescheduling Could Hinder Legalization For 'Another 50 Years'
February 26, 2024
From Benzinga
DEA-sanctioned: Jamaica Sends First-ever Legal Cannabis Products To US For Analytical Testing
February 25, 2024
From Benzinga
DEA Clears This NASDAQ-Traded 'Plant-Touching' Firm To Research And Produce Schedule I And II Plant-Based Drugs
February 23, 2024
From Benzinga
Law Enforcement Leaders Urge Biden To Reclassify Cannabis, Citing 'Direct Conflict Between State And Federal Laws'
February 23, 2024
From Benzinga
Earn Passive Income from the U.S. Government With These 2 Stocks
February 23, 2024
From Benzinga
FDA Gathers Public Social Media Data To Better Understand Cannabis Users As Part Of Its Effort Toward Rescheduling Marijuana
February 20, 2024
From Benzinga
EXCLUSIVE: 'Undo The Harms Of The War On Drugs,' Says Glass House CEO
February 15, 2024
Tickers
DEA
From Benzinga
Back to the Boardroom: How 'Return to Work' is Revitalizing America's Office REITs
February 15, 2024
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.